,使Pin1

Wang Wang1, Qizhou Jiang2, Jiaxin Tao2

  • 1School of Basic Medicine, Nanchang Medical College, Nanchang 330006, PR China; Key Laboratory of Pharmacodynamics and Quality Evaluation on ant-inflammatory Chinese Herbs, Jiangxi Administration of Traditional Chinese Medicine, Nanchang 330006, PR China; Key Laboratory of Pharmacodynamics and Safety Evaluation, Health Commission of Jiangxi Province, Nanchang 330006, PR China.

PubMed
概括

研究人员确定了四种FDA批准的药物,可以抑制Peptidyl-prolyl cis/trans异构酶Pin1,这是预防恶性瘤的关键蛋白质. 贝克萨罗特别有前途,为癌症治疗开发提供了潜在的新途径.